Related Experiment Video
Updated: Jun 22, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetics in relation to cardiac diseases: Implications for general practitioners
1MBChB, MRCP (UK), FRACP, Director of Electrophysiology and Clinical Lead in Cardiac Genomics, Cairns Hospital, Cairns, Qld.
Genetics significantly impacts cardiovascular diseases (CVDs), influencing risk and treatment. General practitioners can leverage genetic insights for better patient assessment and personalized care strategies.
Area of Science:
- Genetics and Cardiovascular Medicine
- Medical Practice and Public Health
Background:
- Cardiovascular diseases (CVDs) represent a major global health concern.
- Genetic factors are increasingly recognized as crucial contributors to CVDs, alongside traditional risk factors.
- This highlights the need for general practitioners (GPs) to adapt their diagnostic and management strategies.
Purpose of the Study:
- To explore the influence of genetics on cardiovascular diseases (CVDs).
- To examine the implications of genetic factors for general practitioners (GPs).
- To discuss the role of genetic insights in enhancing risk assessment and personalized patient care for CVDs.
Main Methods:
- Review of current literature on genetic factors in CVDs.
- Analysis of monogenic disorders (e.g., inherited cardiomyopathies, channelopathies) and their inheritance patterns.
- Examination of polygenic risk and the application of polygenic risk scores (PRS).
- Discussion of pharmacogenetics for tailored drug interventions.
Main Results:
- Monogenic disorders like inherited cardiomyopathies and Long QT syndrome have clear inheritance patterns.
- Polygenic risk scores offer precise assessment of CVD susceptibility.
- Pharmacogenetics enables personalized drug selection based on genetic profiles.
- Challenges in genetic testing accessibility and ethical considerations were noted.
Conclusions:
- Integrating genetic information into cardiovascular care can significantly reduce the global burden of CVDs.
- Personalized risk assessment and treatment strategies based on genetic profiles promise improved patient outcomes.
- Further research and implementation strategies are needed to overcome current challenges in genetic medicine adoption.
Related Concept Videos
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Incomplete Dominance
Animal Mitochondrial Genetics
Pathophysiology of Cardiac Performance
Mechanism of Cardiac Arrhythmias

